K

Korea Pharma Co Ltd
KOSDAQ:032300

Watchlist Manager
Korea Pharma Co Ltd
KOSDAQ:032300
Watchlist
Price: 13 170 KRW -1.2%
Market Cap: 143.7B KRW

Gross Margin
Korea Pharma Co Ltd

40.6%
Current
44%
Average
48.6%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
40.6%
=
Gross Profit
34.6B
/
Revenue
85.3B

Gross Margin Across Competitors

No Stocks Found

Korea Pharma Co Ltd
Glance View

Market Cap
143.6B KRW
Industry
Pharmaceuticals

KOREA PHARMA Co., Ltd. is engaged in the manufacturing of pharmaceutical products. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2020-08-10. The firm's main products include digestive system solvents, antidepressants, blood circulation agents, antidementia drugs, schizophrenia medicines and others.

Korea Pharma Co Ltd Intrinsic Value
HIDDEN
Show
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
40.6%
=
Gross Profit
34.6B
/
Revenue
85.3B
What is the Gross Margin of Korea Pharma Co Ltd?

Based on Korea Pharma Co Ltd's most recent financial statements, the company has Gross Margin of 40.6%.

Back to Top